CN101199822A - Capsule medicament for treating qi blood estrangement vitiligo - Google Patents
Capsule medicament for treating qi blood estrangement vitiligo Download PDFInfo
- Publication number
- CN101199822A CN101199822A CNA2007101604329A CN200710160432A CN101199822A CN 101199822 A CN101199822 A CN 101199822A CN A2007101604329 A CNA2007101604329 A CN A2007101604329A CN 200710160432 A CN200710160432 A CN 200710160432A CN 101199822 A CN101199822 A CN 101199822A
- Authority
- CN
- China
- Prior art keywords
- blood
- vitiligo
- treating
- medicine
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The invention relates to a Chinese traditional medicine preparation, which is a capsule drug for treating qi-blood imbalance-type vitiligo. The medicine is prepared by the raw materials of the following weights: sappan wood, safflower, Ligusticum Chuanxiong each of which is of 50g, and tribulus terrestris and curcuma, each of which is of 40g. The invention has the advantages of novel ingredient, cheap cost, convenient preparation and notable effect.
Description
Technical field:
The present invention relates to a kind of Chinese medicine preparation, promptly treat the very good leukodermic pharmaceutical capsules of the qi-blood disharmony type of a kind of treatment of qi-blood disharmony type vitiligo effect.
Background technology:
Vitiligo is a kind of skin pigment obstacle dermatoses, and its symptom shows as: occur white dot in normal skin, not of uniform size, shape differs, the no scurf of white macula performance, pimple.The reason that causes, Chinese medicine think attack with deficiency of the liver and kindey, blood deficiency wind, qi-blood disharmony etc. relevant.Qi-blood disharmony type vitiligo is by due to qi-blood disharmony, the hematogenous blockage.At present, it is more to treat the leukodermic medicine of qi-blood disharmony type both at home and abroad, has Western medicine that Chinese medicine is also arranged, and still, has shortcomings such as drug price height, medical expense is big, effect is not ideal enough.
Summary of the invention:
The objective of the invention is at present weak point on the qi-blood disharmony type vitiligo of treatment, and a kind of new raw material of Chinese medicine combination, leukodermic pharmaceutical capsules of the qi-blood disharmony type of treatment and preparation method evident in efficacy are provided.
Technical scheme of the present invention is achieved in that
The leukodermic pharmaceutical capsules of the qi-blood disharmony type of a kind of treatment, its medicine is to be made by the raw material of following weight parts: Lignum Sappan, Flos Carthami, each 50 gram of Rhizoma Chuanxiong, Fructus Atriplicis Sibiricae, each 40 gram of Rhizoma Curcumae Longae.
The leukodermic pharmaceutical capsules of the qi-blood disharmony type of a kind of treatment, the preparation method of its medicine is: with above-mentioned raw material of Chinese medicine oven dry, be ground into thin medicated powder, cross 120 mesh sieves, mix homogeneously is used ultraviolet sterilization 12 hours, the Capsules of packing into No. 1, every net weight 0.5 gram.
The leukodermic pharmaceutical capsules of the qi-blood disharmony type of a kind of treatment, its Therapeutic Principle is QI and blood regulating, dispelling wind for relieving itching.On composition of raw materials, follow the property of medicine through belonging to, lay particular stress on QI and blood regulating, take into account whole machine balancing, the dispelling wind for relieving itching of stopping over.In the medicine Lignum Sappan have the promoting the circulation of blood dissipating blood stasis, the effect of stimulating the menstrual flow, Flos Carthami has promoting blood circulation to remove blood stasis, the effect of stimulating the menstrual flow, Rhizoma Chuanxiong has blood-activating and qi-promoting, the wind effect of loosing, soothing the liver, dispeling the wind effect that Fructus Atriplicis Sibiricae has, Rhizoma Curcumae Longae has the removing blood stasis circulation of qi promoting, long-pending the acting on of loosing.Above-mentioned Chinese medicine is through dialectical compatibility, complements each other using, thereby given play to QI and blood regulating effectively, the effect of dispelling wind for relieving itching, to reach the purpose of curing qi-blood disharmony type vitiligo.
The present invention has following characteristics: fill a prescription novel, with low cost, easy to prepare, effect is remarkable.
Using method:
Consumption: obey 10 grams every day, divide 2 clothes down, each 5 grams, promptly 10.Method: warm water delivery service.
The taboo item:
1, fried sticky, the cold solid food hard, nondigestible and excitatory of taboo edible oil during the medication.
2, forbid taking orally.
Clinical therapeutic efficacy:
Criterion of therapeutical effect: the leukodermic pharmaceutical capsules of the qi-blood disharmony type of a kind of treatment is treated the curative effect of qi-blood disharmony type vitiligo and is judged whether mainly be dependent on qi-blood disharmony type vitiligo symptom disappears.Medication 30 days was 1 course of treatment.Concrete curative effect is divided following three grades: cure---and qi-blood disharmony type vitiligo symptom all disappears; Taking a turn for the better---qi-blood disharmony type vitiligo symptom obviously alleviates; Invalid---after medication 1 course of treatment, qi-blood disharmony type vitiligo symptom has no to disappear.
Effect: with qi-blood disharmony type patients with vitiligo 14 examples of Drug therapy of the present invention, treat 1 course of treatment, wherein cure 11 examples, 3 examples that take a turn for the better, cure rate is 79%, effective percentage is 100%.
Claims (1)
1. the leukodermic pharmaceutical capsules of the qi-blood disharmony type of treatment is characterized in that this medicine is to be made by the raw material of following weight parts: Lignum Sappan, Flos Carthami, each 50 gram of Rhizoma Chuanxiong, Fructus Atriplicis Sibiricae, each 40 gram of Rhizoma Curcumae Longae.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2007101604329A CN101199822B (en) | 2007-12-13 | 2007-12-13 | Capsule medicament for treating qi blood estrangement vitiligo |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2007101604329A CN101199822B (en) | 2007-12-13 | 2007-12-13 | Capsule medicament for treating qi blood estrangement vitiligo |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101199822A true CN101199822A (en) | 2008-06-18 |
| CN101199822B CN101199822B (en) | 2011-10-12 |
Family
ID=39515306
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2007101604329A Expired - Fee Related CN101199822B (en) | 2007-12-13 | 2007-12-13 | Capsule medicament for treating qi blood estrangement vitiligo |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101199822B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102872235A (en) * | 2012-09-14 | 2013-01-16 | 华水土 | Decoction medicament for treating qi and blood disharmony type vitiligo |
| CN114796311A (en) * | 2021-01-27 | 2022-07-29 | 保定华仁白癜风医院 | Pill of vernonia amygdalina for eliminating leukosis |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100546635C (en) * | 2006-10-17 | 2009-10-07 | 北京万寿通医药科技有限公司 | The leukodermic Chinese medicine preparation of a kind of treatment |
-
2007
- 2007-12-13 CN CN2007101604329A patent/CN101199822B/en not_active Expired - Fee Related
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102872235A (en) * | 2012-09-14 | 2013-01-16 | 华水土 | Decoction medicament for treating qi and blood disharmony type vitiligo |
| CN114796311A (en) * | 2021-01-27 | 2022-07-29 | 保定华仁白癜风医院 | Pill of vernonia amygdalina for eliminating leukosis |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101199822B (en) | 2011-10-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101199822B (en) | Capsule medicament for treating qi blood estrangement vitiligo | |
| CN101199830B (en) | Heat-transfer dose medicament for treating migraine | |
| CN101244156B (en) | Hydropathic compress medicament for treating folliculitis | |
| CN101194988A (en) | Powder medicament for treating mouth ulcer | |
| CN101780131A (en) | Drug for treating headache and preparation method thereof | |
| CN101288715A (en) | Orally-taken Chinese medicine for treating headache due to wind-heat evil | |
| CN101194956B (en) | Fumigation medicament for treating archoptosis | |
| CN101199688B (en) | Tincture dose medicament for treating part frozen | |
| CN101204525B (en) | Tincture medicine for burn | |
| CN101204456B (en) | Marinating medicine for hands and feet psoriasis | |
| CN101185697B (en) | Ointment medicine for treating anal fissure | |
| CN101919939A (en) | Traditional Chinese medicine for oral administration for treating headache due to pathogenic wind-heat | |
| CN101194974B (en) | Exterior washing medicament for treating impetigo | |
| CN101204489B (en) | Hydropathic compress medicine for verruca plana | |
| CN101199732A (en) | Mud plaster medicament for treating corn | |
| CN101199589B (en) | Tincture medicament for treating face vifiligo | |
| CN101199786B (en) | Medicinal oil medicament for treating psoriasis | |
| CN101194928B (en) | Fumigation medicament for treating scabies | |
| CN101195010B (en) | Powder medicament for treating acute soft tissue injury | |
| CN101306168B (en) | Traditional Chinese medicine taken orally for treating dry seborrheic dermatitis | |
| CN101199695B (en) | Powders medicament for treating sinusitis | |
| CN101199724B (en) | Oral administration Chinese medicine for treating liver stomach discord type hematemesis | |
| CN101204473B (en) | Chinese traditional medicine preparation for abcchia rosacea | |
| CN101204507B (en) | Tincture medicine for brandy nose | |
| CN101194933B (en) | External washing medicament for treating miliaria tumefaction |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20111012 Termination date: 20111213 |